GuidelineVirchows Archiv : an international journal of pathology2013
Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Guideline in Virchows Archiv : an international journal of pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale.European journal of epidemiology · 2017Trial
- Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer.World journal of urology · 2016Trial
- Diagnostic discordance in outside prostate biopsies: Implications for active surveillance patient selection.Investigative and clinical urology · 2026Article
- The 'Co-Qual': Real-time assessment of prostate biopsy core quality using fluorescence confocal microscopy.BJU international · 2026Article
- The impact of the relationship between lesion diameter and total core length on the detection rate of clinically significant prostate cancer for PI-RADS 3 lesions.World journal of urology · 2024Article
- Incidence and Predicting Factors of Histopathological Features at Robot-Assisted Radical Prostatectomy in the mpMRI Era: Results of a Single Tertiary Referral Center.Medicina (Kaunas, Lithuania) · 2023Article
- Immunohistochemical investigation of cytokine expression levels as biomarkers in transrectal ultrasound-guided needle biopsy specimens of prostate adenocarcinoma.Molecular and clinical oncology · 2021Article
- MiR-93/miR-375: Diagnostic Potential, Aggressiveness Correlation and Common Target Genes in Prostate Cancer.International journal of molecular sciences · 2020Article
- Relative Contribution of Sampling and Grading to the Quality of Prostate Biopsy: Results from a Single High-volume Institution.European urology oncology · 2020Article
- Are 10-, 10-12-, or > 12-mm prostate biopsy core quality control cutoffs reasonable?World journal of urology · 2018Article
- Do longer or shorter cores yield more cancer?World journal of urology · 2018Article
- Handling and reporting of transperineal template prostate biopsy in Europe: a web-based survey by the European Network of Uropathology (ENUP).Virchows Archiv : an international journal of pathology · 2018Article
- Longer biopsy cores do not increase prostate cancer detection rate: A large-scale cohort study refuting cut-off values indicated in the literature.Turkish journal of urology · 2017Article
- Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer.Oncotarget · 2017Article
- Optimizing safety and accuracy of prostate biopsy.Current opinion in urology · 2016Review
- The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.Pathology oncology research : POR · 2016Article
- Minimum 6 mm core length is strongly predictive for the presence of glandular tissue in transrectal prostate biopsy.World journal of urology · 2015Article
- Gleason underestimation is predicted by prostate biopsy core length.World journal of urology · 2015Article
- Length of prostate biopsies is not necessarily compromised by pooling multiple cores in one paraffin block: an observational study.BMC clinical pathology · 2015Article
- Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists.Virchows Archiv : an international journal of pathology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The histopathological examination of a prostate biopsy is the basis of prostate cancer diagnostics. Prostate cancer grade and extent of cancer in the diagnostic biopsy are important determinants of patient management. Quality of the prostate biopsy and its processing may influence the outcome of the histopathological evaluation. Further, an unambiguous and concise pathology reporting is essential for an appropriate clinical decision process. Since our initial report in 2003, there have been several practice changes, including the increased uptake of follow-up biopsies of patients who are under active surveillance, increasingly taken under guidance of MRI, or who underwent a prostate-sparing therapy. Therefore, we investigated the literature on the current pathology practices and recommendations with regard to prostate biopsy processing and reporting, both at initial diagnosis and in the context of follow-up biopsies in order to update our guidelines on the optimal processing and reporting of prostate biopsies.
Indexed as
Identifiers
23918245What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.